Abstract:CD4(+) T cells play critical roles in orchestrating adaptive immune responses. Their activation and proliferation are critical steps that occur before they execute their biological functions. Despite the important role of this process, the underlying molecular events are not fully understood. MicroRNAs (miRNAs) have been shown to play important roles in lymphocyte development and function. However, the miRNAs that regulate T-cell differentiation, activation and proliferation are still largely unknown. In our previous study, using a miRNA array, we found that several miRNAs (including miR-202, 33b, 181c, 568 and 576) are differentially expressed between resting and activated CD4(+) T cells. In this study, we focused on the function of miR-568 during CD4(+) T-cell activation. We showed that the expression level of miR-568 decreased during the activation of T cells, including Jurkat cells and human peripheral blood CD4(+) T cells. When Jurkat or human peripheral blood CD4(+) T cells were transfected with miR-568 mimics, cell activation was significantly inhibited, as shown by the inhibited expression of activation markers such as CD25, CD69 and CD154; decreased IL-2 production; and inhibited cell proliferation. Using software predictions and confirmatory experiments, we demonstrated that nuclear factor of activated T cells 5 (NFAT5) is a target of miR-568. Treg cells are an important CD4(+) T-cell subpopulation, so we also evaluated the function of miR-568 in Treg-cell activation and differentiation. We showed that the miR-568 level decreased, while the NFAT5 protein level increased during CD4(+)CD25(+) Treg-cell activation, and the transfection of miR-568 mimics inhibited the NFAT5 expression, inhibited the production of both TGF-β and IL-10 and also inhibited the proliferation of Treg cells. Our further study showed that over-expression of miR-568 can inhibit Treg-cell differentiation and can inhibit the suppressive effect of these cells on effector cells. In addition, inhibition of NFAT5 by siRNA-mediated knockdown can inhibit the activation and differentiation of Treg cells. These findings reveal that miR-568 can inhibit the activation and function of both CD4(+) T cells and Treg cells by targeting NFAT5. Since miR-568 plays an important role in both CD4(+) T cells and Treg cells, these findings may provide leads for the development of novel treatments for human inflammatory and autoimmune diseases.

Cbl-b inhibited CD4+T cell activation by regulating the expression of miR-99a/miR-125b

Protein Tyrosine Phosphatase SHP-1 Modulates T Cell Responses by Controlling Cbl-b Degradation

Ablation of Cbl-b and C-Cbl in Dendritic Cells Causes Spontaneous Liver Cirrhosis Via Altering Multiple Properties of CD103+ Cdc1s

MicroRNA-10a Negatively Regulates CD4+ T Cell IL-10 Production Through Suppression of Blimp1.

NF-κB Downregulates Cbl-b Through Binding and Suppressing Cbl-b Promoter in T Cell Activation.

MiR-525-5p Modulates Cell Proliferation, Cell Cycle, and Apoptosis in Burkitt’s Lymphoma by Targeting MyD88 and Regulating the NF-κB Signaling Pathway

Up-Regulation of Cbl-B is Associated with Lsectin-Mediated Inhibition of Different Cd4(+) T-Cell Subsets

Cbl-b inhibition promotes less differentiated phenotypes of T cells with enhanced cytokine production

Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell Activation.

Negative Regulation of Cd40-Mediated B Cell Responses by E3 Ubiquitin Ligase Casitas-B-Lineage Lymphoma Protein-B

B and T Lymphocyte Attenuator is a Target of Mir-155 During Naive CD 4 + T Cell Activation

MicroRNA-126 regulates the induction and function of CD4+ Foxp3+ regulatory T cells through PI3K/AKT pathway

Cbl-b restrains priming of pathogenic Th17 cells via the inhibition of IL-6 production by macrophages

Human activated CD4+ T lymphocytes increase IL-2 expression by downregulating microRNA-181c

A direct interaction between the adaptor protein Cbl-b and the kinase zap-70 induces a positive signal in T cells.

MiR-568 Inhibits the Activation and Function of CD4⁺ T Cells and Treg Cells by Targeting NFAT5.

Mir-128-2 Inhibits Common Lymphoid Progenitors From Developing Into Progenitor B Cells

miR-155 Regulates IL-10-Producing CD24 hi CD27 + B Cells and Impairs Their Function in Patients with Crohn's Disease.

CBX4 Promotes Antitumor Immunity by Suppressing Pdcd1 Expression in T Cells.

The transcription factor Zfp281 sustains CD4 + T lymphocyte activation through directly repressing Ctla-4 transcription

miR-124-3p enhances dendritic cell-mediated anti-tumor immunity by targeting CYLD/4-1BBL pathway